+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Epidural Abscess Treatment Market Report 2025

  • PDF Icon

    Report

  • 200 Pages
  • March 2025
  • Region: Global
  • The Business Research Company
  • ID: 5931022
This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The epidural abscess treatment market size has grown strongly in recent years. It will grow from $41.11 billion in 2024 to $44.01 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing prevalence of epidural abscesses, high healthcare expenditure, increasing awareness of the disease, growing demand for combination therapies.

The epidural abscess treatment market size is expected to see strong growth in the next few years. It will grow to $56.78 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to growing geriatric population, government initiatives, investment in epidural abscess research and development, growing incidence of spinal epidural abscesses. Major trends in the forecast period include innovations in healthcare technology, digital health technologies in epidural abscess care, artificial intelligence (AI) in epidural abscess diagnosis and treatment, affordable epidural abscess treatments.

The growth of the epidural abscess treatment market is expected to be driven by the rising prevalence of neurological disorders. Neurological disorders encompass medical conditions that affect the nervous system, which includes the brain, spinal cord, and nerves. Common examples of neurological disorders include acute spinal cord injury, Alzheimer's Disease, Amyotrophic Lateral Sclerosis (ALS), among others. Epidural abscess treatment is a crucial approach for managing these neurological disorders. It typically involves timely surgical drainage of the abscess and antibiotic therapy, which helps prevent compression of the spinal cord and nerves, relieving pressure. For instance, as of March 2022, the Alzheimer's Association, a nonprofit organization in the United States, reported that approximately 6.7 million Americans aged 65 and older are living with Alzheimer's in 2023. This number is projected to increase to 12.7 million by 2050. Consequently, the growing prevalence of neurological disorders is serving as a driving factor for the expansion of the epidural abscess treatment market.

The growing prevalence of intravenous drug use is expected to drive the expansion of the epidural abscess treatment market in the future. Intravenous drug use involves injecting drugs directly into the bloodstream with a hypodermic needle and syringe. This practice can lead to epidural abscesses when contaminated needles or drugs introduce bacteria or pathogens into the bloodstream, increasing the occurrence of the condition and fueling demand for specialized treatments, care, and prevention programs. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that in 2022-2023, 1.4% of individuals aged 14 and older had injected a drug at least once in their lifetime, while 0.2% had injected a drug within the past year. As a result, the rise in intravenous drug use is expected to drive the growth of the epidural abscess treatment market.

In March 2022, AbbVie Inc., a pharmaceutical company based in the United States, completed the acquisition of Syndesi Therapeutics SA for an approximate sum of $1 billion. This strategic acquisition is poised to facilitate AbbVie Inc.'s expansion within the field of neuroscience by incorporating novel synapse vesicle protein 2A modulators into its portfolio. Syndesi Therapeutics SA, headquartered in Belgium, is a biotechnology company with a focus on the development of therapies for spinal disorders, including conditions such as epidural abscesses.

Major companies operating in the epidural abscess treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Astellas Pharma, Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, UCB Pharma, Sun Pharmaceutical Industries Limited, Kyowa Hakko Kirin Co. Ltd., Ferring B.V., Hikma Pharmaceuticals PLC, Intas Pharmaceuticals Limited, Alembic Limited, Zydus Lifesciences Ltd., Lupin Limited, Mallinckrodt Pharmaceuticals.

North America was the largest region in the epidural abscess treatment market in 2024. The regions covered in epidural abscess treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the epidural abscess treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The epidural abscess treatment market consists of revenues earned by entities by providing surgical intervention, myelography, magnetic resonance imaging (MRI) and computed tomography (CT) scans. The market value includes the value of related goods sold by the service provider or included within the service offering. The epidural abscess treatment market also includes sales of vancomycin, gentamicin and ceftriaxone. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Epidural abscess treatment refers to the treatment of a rare disorder that is characterized by an infection in the area between the bones of the skull or spine and the membranes covering the brain and spinal cord. Epidural abscess treatment is used to manage symptoms, slow down the progression of the disease and prevent complications.

The main types of epidural abscesses are intracranial and intraspinal. An intracranial epidural abscess refers to an infection between the skull's bones and the membranes encasing the brain and spinal cord. These can be treated by various treatments, including antifungals, antibiotics and surgery, which are used by various end-users, such as hospitals, pharmacies, specialty clinics and others.

The epidural abscess treatment market research report is one of a series of new reports that provides epidural abscess treatment market statistics, including epidural abscess treatment industry global market size, regional shares, competitors with an epidural abscess treatment market share, detailed epidural abscess treatment market segments, market trends and opportunities and any further data you may need to thrive in the epidural abscess treatment industry. This epidural abscess treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Epidural Abscess Treatment Market Characteristics3. Epidural Abscess Treatment Market Trends and Strategies4. Epidural Abscess Treatment Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, Covid and Recovery on the Market
5. Global Epidural Abscess Treatment Growth Analysis and Strategic Analysis Framework
5.1. Global Epidural Abscess Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis of End Use Industries
5.3. Global Epidural Abscess Treatment Market Growth Rate Analysis
5.4. Global Epidural Abscess Treatment Historic Market Size and Growth, 2019-2024, Value ($ Billion)
5.5. Global Epidural Abscess Treatment Forecast Market Size and Growth, 2024-2029, 2034F, Value ($ Billion)
5.6. Global Epidural Abscess Treatment Total Addressable Market (TAM)
6. Epidural Abscess Treatment Market Segmentation
6.1. Global Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intracranial
  • Intraspinal
6.2. Global Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antifungal
  • Antibiotics
  • Surgery
6.3. Global Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Pharmacy
  • Specialty Clinics
  • Other End-Users
6.4. Global Epidural Abscess Treatment Market, Sub-Segmentation of Intracranial, by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Brain Abscess
  • Subdural Abscess
  • Epidural Abscess in the Cranium
6.5. Global Epidural Abscess Treatment Market, Sub-Segmentation of Intraspinal, by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cervical Epidural Abscess
  • Thoracic Epidural Abscess
  • Lumbar Epidural Abscess
  • Sacral Epidural Abscess
7. Epidural Abscess Treatment Market Regional and Country Analysis
7.1. Global Epidural Abscess Treatment Market, Split by Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Epidural Abscess Treatment Market, Split by Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Epidural Abscess Treatment Market
8.1. Asia-Pacific Epidural Abscess Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Epidural Abscess Treatment Market
9.1. China Epidural Abscess Treatment Market Overview
9.2. China Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Epidural Abscess Treatment Market
10.1. India Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Epidural Abscess Treatment Market
11.1. Japan Epidural Abscess Treatment Market Overview
11.2. Japan Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Epidural Abscess Treatment Market
12.1. Australia Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Epidural Abscess Treatment Market
13.1. Indonesia Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Epidural Abscess Treatment Market
14.1. South Korea Epidural Abscess Treatment Market Overview
14.2. South Korea Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Epidural Abscess Treatment Market
15.1. Western Europe Epidural Abscess Treatment Market Overview
15.2. Western Europe Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Epidural Abscess Treatment Market
16.1. UK Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Epidural Abscess Treatment Market
17.1. Germany Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Epidural Abscess Treatment Market
18.1. France Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Epidural Abscess Treatment Market
19.1. Italy Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Epidural Abscess Treatment Market
20.1. Spain Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Epidural Abscess Treatment Market
21.1. Eastern Europe Epidural Abscess Treatment Market Overview
21.2. Eastern Europe Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Epidural Abscess Treatment Market
22.1. Russia Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Epidural Abscess Treatment Market
23.1. North America Epidural Abscess Treatment Market Overview
23.2. North America Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Epidural Abscess Treatment Market
24.1. USA Epidural Abscess Treatment Market Overview
24.2. USA Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Epidural Abscess Treatment Market
25.1. Canada Epidural Abscess Treatment Market Overview
25.2. Canada Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Epidural Abscess Treatment Market
26.1. South America Epidural Abscess Treatment Market Overview
26.2. South America Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Epidural Abscess Treatment Market
27.1. Brazil Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Epidural Abscess Treatment Market
28.1. Middle East Epidural Abscess Treatment Market Overview
28.2. Middle East Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Epidural Abscess Treatment Market
29.1. Africa Epidural Abscess Treatment Market Overview
29.2. Africa Epidural Abscess Treatment Market, Segmentation by Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Epidural Abscess Treatment Market, Segmentation by Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Epidural Abscess Treatment Market, Segmentation by End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Epidural Abscess Treatment Market Competitive Landscape and Company Profiles
30.1. Epidural Abscess Treatment Market Competitive Landscape
30.2. Epidural Abscess Treatment Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
31. Epidural Abscess Treatment Market Other Major and Innovative Companies
31.1. Novartis AG
31.2. Sanofi S.a.
31.3. Bristol-Myers Squibb Company
31.4. AstraZeneca plc
31.5. Abbott Laboratories
31.6. Eli Lilly and Company
31.7. Gilead Sciences Inc.
31.8. Amgen Inc.
31.9. Teva Pharmaceutical Industries Ltd.
31.10. Mylan N.V.
31.11. Astellas Pharma
31.12. Daiichi Sankyo Company Limited
31.13. Boehringer Ingelheim International GmbH
31.14. UCB Pharma
31.15. Sun Pharmaceutical Industries Limited
32. Global Epidural Abscess Treatment Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Epidural Abscess Treatment Market34. Recent Developments in the Epidural Abscess Treatment Market
35. Epidural Abscess Treatment Market High Potential Countries, Segments and Strategies
35.1 Epidural Abscess Treatment Market in 2029 - Countries Offering Most New Opportunities
35.2 Epidural Abscess Treatment Market in 2029 - Segments Offering Most New Opportunities
35.3 Epidural Abscess Treatment Market in 2029 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Epidural Abscess Treatment Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on epidural abscess treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for epidural abscess treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The epidural abscess treatment market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Intracranial; Intraspinal
2) By Treatment: Antifungal; Antibiotics; Surgery
3) By End-User: Hospital; Pharmacy; Specialty Clinics; Other End-Users

Subsegments:

1) By Intracranial: Brain Abscess; Subdural Abscess; Epidural Abscess in the Cranium
2) By Intraspinal: Cervical Epidural Abscess; Thoracic Epidural Abscess; Lumbar Epidural Abscess; Sacral Epidural Abscess

Key Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.; Bayer AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

Some of the major companies featured in this Epidural Abscess Treatment market report include:
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • AbbVie Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Bristol-Myers Squibb Company
  • AstraZeneca plc
  • Abbott Laboratories
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Astellas Pharma
  • Daiichi Sankyo Company Limited
  • Boehringer Ingelheim International GmbH
  • UCB Pharma
  • Sun Pharmaceutical Industries Limited
  • Kyowa Hakko Kirin Co. Ltd.
  • Ferring B.V.
  • Hikma Pharmaceuticals plc
  • Intas Pharmaceuticals Limited
  • Alembic Limited
  • Zydus Lifesciences Ltd.
  • Lupin Limited
  • Mallinckrodt Pharmaceuticals

Table Information